India's hospitals grapple with a high rate of medication errors
A recent systematic review highlights that approximately one in three hospitalised patients in India experiences medication errors. These errors, ranging from wrong doses to mistimed drugs, pose significant risks to patient safety and occur most frequently during the prescribing and administration stages. Systemic issues like heavy workloads and poor communication contribute to this problem.
Key Highlights
- One in three hospitalized Indian patients experience medication errors.
- Prescribing and administration are the most common stages for errors.
- Heavy workloads and poor communication exacerbate the issue.
- Intensive care and emergency departments are particularly vulnerable.
- Medication errors can lead to temporary harm and prolonged hospital stays.
A significant portion of hospitalised patients in India, estimated at one in three, are affected by medication errors, according to a comprehensive systematic literature review (SLR) published in the Indian Journal of Critical Care Medicine. The study, which analysed data from January 2014 to April 2025 across 40 studies involving over 307,000 patients, found a median medication error incidence rate of 34.11%. This means that for every 100 hospitalised patients, about 34 experienced at least one medication error during their stay. The overall frequency rate of medication errors was reported at 26.74%, indicating that more than a quarter of clinical encounters involved such errors. These findings represent one of the most extensive efforts to quantify the problem of medication errors in Indian hospitals.
The SLR underscores the substantial challenges these errors pose to patient safety in India and highlights the critical need for targeted interventions. The errors encompass a range of issues, including wrong doses, mistimed medications, and drugs intended for other patients. The review indicates that these errors are not rare occurrences but are routine within Indian hospitals.
High-risk environments such as Intensive Care Units (ICUs) and emergency departments are particularly vulnerable. The review noted ICU error rates reaching 36.53%, while emergency departments reported even higher frequency rates, as high as 74%. This heightened risk in critical care settings is attributed to complex treatment protocols and intense time pressure, which increase the likelihood of errors.
Errors most frequently occur during the prescribing stage (40% of cases) and the administration stage (31%). These stages significantly outpace errors related to transcription and dispensing. The study also detailed the clinical outcomes of these errors: while many were minor, 8.9% required close monitoring, 2.2% resulted in temporary harm necessitating intervention, and a smaller percentage, between 0.1% and 1.2%, led to prolonged hospitalisation. In specialised critical care units, high-alert medications were associated with a rate of 160.12 incidents per 1,000 patient days, underscoring the severity of potential harm.
The causes of medication errors in Indian hospitals are identified as a combination of systemic and individual factors. Heavy workloads, insufficient staffing, fatigue among healthcare professionals, and poor communication between departments create an environment where errors are almost inevitable. Nursing staff, in particular, bear a heavy burden. Other contributing factors include illegible handwriting, verbal orders, excessive prescribing, confusing drug nomenclature, and packaging or labelling issues. Lack of a clinical pharmacist in many settings, insufficient patient counselling, and a lack of qualified and skilled personnel also play a role, especially in rural areas.
Patient safety has been recognised as a critical challenge for India's healthcare system. Initiatives are underway to improve it, including the establishment of the Quality Council of India and the National Accreditation Board for Hospitals and Health Care Providers (NABH) to standardise care and ensure safety. India's National Patient Safety Implementation and Framework (NPSIF 2018-2025) also outlines objectives to improve structural systems, report and learn from adverse events, ensure a competent workforce, and implement global safety campaigns. However, the persistence of significant medication error rates indicates that further targeted interventions are crucial to mitigate these risks and enhance patient safety across the country. The findings of this SLR strongly emphasize the need for a systematic approach to reduce medication errors, particularly those with severe consequences.
Frequently Asked Questions
What is a medication error?
A medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the healthcare professional, patient, or consumer. This can include errors in prescribing, dispensing, administration, or patient use of medication.
How common are medication errors in Indian hospitals?
A systematic literature review indicates that approximately one in three (34.11% median incidence rate) hospitalised patients in India experience at least one medication error during their hospital stay. The overall frequency rate is reported at 26.74%.
Which stages of medication use are most prone to errors?
Errors most frequently occur during the prescribing stage (40% of cases) and the administration stage (31%).
What are the consequences of medication errors?
While many medication errors are minor, some can lead to temporary harm requiring intervention (2.2%), prolonged hospitalisation (0.1-1.2%), and in severe cases, permanent harm or death. Errors also erode patient trust in the healthcare system.
What contributes to medication errors in Indian hospitals?
Contributing factors include systemic issues like heavy workloads, insufficient staffing, fatigue, and poor communication between departments. Individual factors such as lack of training, illegible handwriting, and issues with drug nomenclature and labelling also play a role. Limited availability of clinical pharmacists, especially in rural areas, is also a concern.